Dysplasia-associated mass or lesion (DALM) and sporadic adenomas in patients with chronic idiopathic inflammatory bowel disease

Diagnostic Histopathology

Volumn 14, Issue 2, 2008, Pages 110-115

  Cross, Simon S ^a,b,c   Vergani, Patricia ^a,b,c   Stephenson, Timothy J ^a,b,c   Varghese, Mini ^a,b,c   Sidhu, Reena ^a,b,c   Paul Hurlstone, D ^a,b,c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Bcl2; beta catenin; colorectal cancer; DALM; p53; sporadic adenoma; ulcerative colitis

Indexed keywords

BETA CATENIN; PROTEIN BCL 2; PROTEIN P53;

ADENOMA; ARTICLE; CHROMOENDOSCOPY; COLON POLYP; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DYSPLASIA; DYSPLASIA ASSOCIATED MASS; ENDOSCOPIC SURGERY; ENTERITIS; HISTOLOGY; HUMAN; PROCTOCOLECTOMY; ULCERATIVE COLITIS;

EID: 41449091194     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2007.12.006     Document Type: Article

References (12)

1. Blackstone M.O., Riddell R.H., Rogers B.H.G., and Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 80 (1981) 366-374
2. Walsh S.V., Loda M., Torres C.M., Antonioli D., and Odze R.D. P53 and beta catenin expression in chronic ulcerative colitis-associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Am J Surg Pathol 23 (1999) 963-969
3. Segditsas S., and Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25 (2006) 7531-7537
4. Wang J.Y., Wang Y.H., Jao S.W., et al. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene. Oncol Rep 16 (2006) 1245-1252
5. Odze R.D., Brown C.A., Hartmann C.J., Noffsinger A.E., and Fogt F. Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas. Am J Surg Pathol 24 (2000) 1209-1216
6. Odze R.D. Diagnostic problems and advances in inflammatory bowel disease. Mod Pathol 16 (2003) 347-358
7. Talbot I., Price A., and Salto-Tellez M. Biopsy pathology in colorectal disease. 2nd edn (2006), Hodder Arnold, London 319-323
8. Engelsgjerd M., Farraye F.A., and Odze R.D. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 117 (1999) 1288-1294
9. Rubin P.H., Friedman S., Harpaz N., et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 117 (1999) 1295-1300
10. Odze R.D., Farraye F.A., Hecht J.L., and Hornick J.L. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2 (2004) 534-541
11. Hurlstone D.P., Sanders D.S., Atkinson R., et al. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm?. Gut 56 (2007) 838-846
12. Hurlstone D.P., Thomson M., Brown S., Tiffin N., Cross S.S., and Hunter M.D. Confocal endomicroscopy in ulcerative colitis: differentiating dysplasia-associated lesional mass and adenoma-like mass. Clin Gastroenterol Hepatol 5 (2007) 1235-1241